| Alternant INGENIEUR DATA |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Others |
5月 23, 2024 |
| Senior Analyst - Data & Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 22, 2024 |
| HSE Facilities Maintenances Specialist |
Cambridge (USA) |
USA |
Operations |
CTS |
Facilities & Administration |
5月 22, 2024 |
| Equipment Engineer |
Changping County (Beijing) |
China |
Operations |
Innovative Medicines |
Technical Operations |
5月 21, 2024 |
| ALTERNANT Expert en développement des compétences |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
|
Innovative Medicines |
Others |
5月 21, 2024 |
| Sr. Spec. DDIT ISC IES |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
5月 21, 2024 |
| Maintenance Technician (Mechatronics) |
Schaftenau |
Austria |
Operations |
Innovative Medicines |
Technical Operations |
5月 21, 2024 |
| Document Quality Manager |
Hyderabad (Office) |
India |
Biomedical Research |
Pharma Research |
Research & Development |
5月 21, 2024 |
| MR |
Beijing (Beijing) |
China |
International |
Innovative Medicines |
Sales |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Urumqi (Xinjiang Province) |
China |
International |
Innovative Medicines |
Sales |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Analyst – Patient Oriented Programs |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Associate Supply Chain Performance Mngr |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Technical Operations |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Associate Director Data Science |
Hyderabad (Office) |
India |
Operations |
CTS |
Data and Digital |
5月 20, 2024 |
| Principal /Senior Principal Scientist PKS Oncology |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
5月 20, 2024 |
| Senior Vendor Program Manager |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
Research & Development |
5月 20, 2024 |
| (Senior) Clinical Development Medical Director - Rheumatology |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
5月 20, 2024 |
| Hire to Retire Services Specialist |
Selangor |
Malaysia |
People & Organization |
CTS |
Human Resources |
5月 19, 2024 |
| Alternant CONTRÔLE DE GESTION - BPA |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Finance |
Innovative Medicines |
Others |
5月 17, 2024 |
| Clinical Laboratory Scientist, Generalist |
Carlsbad |
USA |
Operations |
Innovative Medicines |
Research & Development |
5月 17, 2024 |
| Manager - Advanced Analytics |
Hyderabad (Office) |
India |
Operations |
CTS |
Data and Digital |
5月 17, 2024 |
| （高级）医药代表 /（资深）产品专员 |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
5月 17, 2024 |
| Alternant MARKET ACCES |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Others |
5月 16, 2024 |
| Alternant MARKET ACCES |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Others |
5月 16, 2024 |
| Alternant MARKET ACCES |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Others |
5月 16, 2024 |
| Microsoft 365 Solution Architect |
Prague |
Czech Republic |
Operations |
CTS |
Technology Transformation |
5月 16, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| Senior Marketing Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
5月 15, 2024 |
| Global Program Clinical Head - Dermatology |
Basel (City) |
USA |
Development |
Innovative Medicines |
Research & Development |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Kunming (Yunnan Province) |
China |
International |
Innovative Medicines |
Sales |
5月 15, 2024 |
| MSL Manager - Hematology |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
5月 14, 2024 |